Macrophage IL-1β mediates atrial fibrillation risk in diabetic mice
JCI Insight · 08.08.2024 · 9 (15)
DOI: 10.1172/jci.insight.171102 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 18.06.2024. Verfasst von Xiaoxu Zhou und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Atrial Fibrillation, Interleukin-1beta, Macrophages, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). The mechanisms underlying DM-associated AF are unclear. AF and DM are both related to inflammation. We investigated whether DM-associated inflammation contributed to AF risk. Mice were fed with high-fat diet to induce type II DM and were subjected to IL-1β antibodies, macrophage depletion by clodronate liposomes, a mitochondrial antioxidant (mitoTEMPO), or a cardiac ryanodine receptor 2 (RyR2) stabilizer (S107). All tests were performed at 36–38 weeks of age. DM mice presented with increased AF inducibility, enhanced mitochondrial reactive oxygen species (mitoROS) generation, and activated innate immunity in the atria, as evidenced by enhanced monocyte chemoattractant protein-1 (MCP-1) expression, macrophage infiltration, and IL-1β levels. Signs of aberrant RyR2 Ca 2+ leak were observed in the atria of DM mice. IL-1β neutralization, macrophage depletion, and exposure to mitoTEMPO and S107 significantly ameliorated the AF vulnerability in DM mice. Atrial overexpression of MCP-1 increased AF occurrence in normal mice through the same mechanistic signaling cascade as observed in DM mice. In conclusion, macrophage-mediated IL-1β contributed to DM-associated AF risk through mitoROS modulation of RyR2 Ca 2+ leak.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Zhou, X., Liu, H., Feng, F., Kang, G. J., Liu, M., Guo, Y., & Dudley, S. C. (2024). Macrophage IL-1β mediates atrial fibrillation risk in diabetic mice. JCI Insight, 9(15). https://doi.org/10.1172/jci.insight.171102
Vancouver
Zhou X, Liu H, Feng F, Kang GJ, Liu M, Guo Y, et al. Macrophage IL-1β mediates atrial fibrillation risk in diabetic mice. JCI Insight. 2024;9(15). doi:10.1172/jci.insight.171102
BibTeX
@article{Zhou2024,
author = {Zhou, Xiaoxu and Liu, Hong and Feng, Feng and Kang, Gyeoung-Jin and Liu, Man and Guo, Yugene and Dudley, Samuel C},
title = {Macrophage IL-1β mediates atrial fibrillation risk in diabetic mice},
journal = {JCI Insight},
year = {2024},
volume = {9},
number = {15},
doi = {10.1172/jci.insight.171102}
}
EUVIMED